Kebai Biotechnology

Nanjing Kebai Biotechnology Co., Ltd. was founded in 2013 and is a comprehensive company specializing in providing proprietary biological products, life medical research outsourcing services, and biological big databases. Over years of development, the company has integrated resources and devoted itself to research and development, gradually establishing products and databases such as the "Tumor Cell Bank", "STR Identification and Comparison Information Database", "DNA/RNA Standard Product Bank", "Drug Target Cell Bank", "Tracer Cell Bank", "Protein Standard Product Bank", and "Gene Expression and Mutation Database". At the same time, it has developed a series of experimental outsourcing service platforms including molecular biology, protein engineering, virus packaging, antibody engineering, cell engineering, and drug discovery. The company attaches great importance to R&D and innovation. Leveraging our superior cell function modification technology and high-precision and flexible gene editing tool platforms, we provide drug screening cell models for multiple disease targets including kinases, GPCRs, and tumor immunology, as well as hundreds of standard reference materials in various forms for genetic diagnosis. We provide products and services for various drug R&D and genetic diagnosis institutions, supporting further understanding of gene functions across all species and the genetic drivers of human diseases, as well as the development of personalized molecular, cellular, and gene therapies. We are a young team of post-80s, post-90s, and post-00s generations, and we sincerely look forward to your joining!*